Yahoo · Sep 29, 2026
Is Aspen Pharmacare (APNHY) Stock Outpacing Its Medical Peers This Year?
Here is how Aspen Pharmacare (APNHY) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.
OTC · APNHY
Healthcare · Drug Manufacturers - Specialty & Generic
$9.77
Up+$0.00 (+0.00%)
Updated Oct 13, 2026, 9:26 AM
SID Score
5.0/10
Composite research score
Smart Money
46/100
Neutral
Price performance · APNHY
1M range · 0 trading sessions · Daily adjusted prices
APNHY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning APNHY.
Company
Market Activity
Research & News
APNHY research
Company profile and research snapshot.
ASPEN PHARMACRE HL UN/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 29, 2026
Here is how Aspen Pharmacare (APNHY) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.
Yahoo · Sep 3, 2026
Aspen Pharmacare Holdings Ltd (APNHF) guides to over 50% NHEPS growth in FY27, driven by a raised sterile EBITDA target and a strong net cash position.
SeekingAlpha · Sep 3, 2026
Aspen Pharmacare Holdings Limited (APNHY) Q4 2026 Earnings Call September 3, 2026 2:30 AM EDTCompany ParticipantsRoy CampbellStephen Saad - Group CEO &...
SeekingAlpha · Sep 3, 2026
2026-09-03. The following slide deck was published by Aspen Pharmacare Holdings Limited in conjunction with their 2026 Q4 earnings call.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning APNHY.
No results
No recent SID articles mention APNHY.